Clinical samples showed significant downregulation of the following genes: CPT2, ACAA2, HPGD and ALDH3A2, while the expression of ENO2, TDO2, CPOX, ACADL and PTPRG was significantly upregulated in the tumor tissue (p < 0.01; Figure 3I). This evidence concerns the gene HPGD and neoplasm.